Birmingham PhD in Cardiovascular Sciences: Tracing Immune-Cell Movement from Inflamed Lungs to Distant Organs

Birmingham PhD in Cardiovascular Sciences: Tracing Immune-Cell Movement from Inflamed Lungs to Distant Organs

Research question and project fit

This doctorate asks why inflammation in one organ selectively injures some distant organs while sparing others exposed to the same circulation. Its distinctive feature is the relationship among inflammatory-cell origin, tissue distribution and molecular evidence, with causality still to establish. It combines demanding animal/imaging work with quantitative analysis, making it most coherent for immunology, vascular/respiratory biology or computational-bioscience applicants willing to train across both sides.

MIBTP programme information lists the project for October 2027 entry, with a 23 November 2026 application deadline and Birmingham registration through 975E PhD in Cardiovascular Sciences MIBTP. It gives no opening date, closing time or time zone, and does not confirm whether the project remains selectable. Awardees receive four-year support and full international tuition coverage. Domestic Chinese applicants may compete under international academic and English rules; the programme's international cohort ceiling and funding selection remain significant constraints. The next useful action is to prepare the specific 975E application and references while checking degree equivalence and project availability, rather than treating supervisor contact as an application. Official project, Birmingham MIBTP application and funding guidance.

Research Problem and Doctoral Work

Chronic lung inflammation can be associated with cardiovascular and other distant complications. The proposed explanation is a molecular “address code”: selected neutrophils leaving the inflamed lung may be captured preferentially by vessels displaying compatible molecular signals. This is a hypothesis, not an established mechanism or clinical intervention.

The advertised research integrates cell-origin information, vascular and immune-cell profiles, quantitative imaging and computational network analysis. Its purpose is to assess whether these complementary forms of evidence support organ-selective inflammatory responses, while distinguishing association from a causal mechanism. Specific models, candidate interactions and experimental validation are matters for supervised research, not established findings or a prescribed intervention pathway.

Training spans photoconversion, intravital microscopy, spectral flow cytometry, single-cell RNA sequencing, quantitative imaging, bioinformatics, network modelling and machine learning. The official project states that relevant licences, mouse lines, platforms and funding are already in place, with banked patient samples and single-cell data available. These are unusually concrete readiness claims; the candidate's protected instrument time, data permissions and initial scope still need confirmation. Project and resources.

The central scientific distinction is between a cell's origin, its accumulation in an organ and its contribution to damage. Increased counts alone cannot establish that cells came from the lung or caused injury; network prioritisation alone cannot establish causal receptor pairing. An achievable thesis needs a clearly bounded tracking comparison and a justified validation stage. This is analysis of the research logic, not an additional advertised work package.

School, Programme and Field Context

The saved official route sits in the Department of Cardiovascular Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham. Birmingham is the registration and degree-awarding institution. Warwick coordinates the broader six-university MIBTP network; participation does not establish a joint degree or require all research to be conducted at Warwick.

Birmingham's QS 2027 overall rank is 68 globally and tenth in the UK. More directly relevant historical research context is REF 2021 Clinical Medicine: 49% four-star and 43% three-star, rather than a project-specific immunology ranking. These describe institutional/subject environment, not a guarantee of individual supervision. Overall ranking, REF profiles.

MIBTP is a four-year cohort programme, with quantitative training and research/industry/technical placements. Its dated 2025 training outline is illustrative; the exact 2027 calendar and locations remain unconfirmed. The ordinary Cardiovascular Sciences doctorate describes minimum 36-month research, annual progress review and thesis/viva, with a mentor, seminars and an active PGR community. That ordinary duration and self-proposed-project application rules must not override the specific four-year MIBTP offer. MIBTP FAQ, training outline, subject PhD.

Supervisors, Facilities and Recent Work

Juma El-Awaisi, a Birmingham Springboard and Asthma + Lung UK Fellow, develops cardio-respiratory thromboinflammation, inter-organ immune-cell movement and advanced imaging. His official profile records fellowship awards from 2025 and a 2022 PhD. Laura Bravo Merodio, Assistant Professor in Health Data Science, contributes systems biology, population-health and computational analysis expertise. This is complementary supervision for linking cell behaviour to high-dimensional evidence; the exact daily experimental/computational split is not published. Juma profile, Laura profile.

Juma's project-linked supervision statement promises at least weekly scheduled meetings, hands-on initial training, a shared laboratory rota and two weeks' notice for feedback on up to 5,000 written words. The microcirculation facility describes multiphoton/spinning-disc intravital imaging and laser Doppler/speckle platforms. Its personnel roster still calls Juma a PhD student and is stale; the current staff and MIBTP pages determine his role. Facility existence does not guarantee a personal booking allocation. Facility context.

Recent Important Publications

The three paper summaries below draw on full institutional abstracts and bibliographic metadata; the full texts were not reviewed.

Impact of chronic hyperglycaemia on the coronary microcirculation (2025)

El-Awaisi and colleagues combine intravital and perfusion imaging to relate metabolic disease to coronary inflammatory-cell behaviour and injury, examining preclinical intervention and reversibility. This supports quantification of microvascular events and organ outcomes. It does not identify lung-origin cells or establish human treatment effects. The repository's DOI field is malformed, so the stable institutional record is used. Paper.

Organ-specific Syk inhibition and thromboinflammation in sickle-cell mice (2025)

The team observes different cell-adhesion and perfusion responses across lung/kidney versus liver/spleen, with an intervention safety tradeoff. This is particularly relevant evidence that organs can respond differently to a shared systemic challenge. It does not prove that the responding cells travelled from the lung or that this project's proposed address code has already been found. Paper.

A Network-Based Association of IBD and Colorectal Cancer Using Proteomics Data (2026)

Bravo Merodio and colleagues combine proteomic markers, multilayer interaction networks and independent transcriptomic assessment to identify shared molecular associations. It supports candidate prioritisation and cross-data reasoning. A network hub or disease association is not a causal receptor–ligand interaction; the PhD's experimental validation remains necessary. Paper.

Funding, Application and Living Cost

The saved Birmingham MIBTP guidance confirms full tuition, including the overseas fee difference, for successful international awardees. The central programme permits international applicants subject to an up-to-30% international cohort ceiling, academic equivalence and selection. That ceiling is not an admission probability. The programme specifies a relevant first or high 2:1; a low 2:1 plus a relevant Master's or at least three years' postgraduate experience may qualify, while a 2:2 or below generally needs exceptional additional experience. Overseas qualifications must be assessed as equivalent. A Master's, journal publication and prior mastery of all methods are not universally required. China's published numeric taught-Master's table should not be treated as a confirmed doctoral cutoff. Current eligibility, PGR entry, China qualification guidance.

The £21,805 annual UKRI rate is for 2026/27, not a confirmed 2027/28 offer. Visa and immigration health surcharge costs are excluded from UKRI support. Research/travel resources are not unrestricted living income. Obtain the future stipend and four-year award terms in writing. UKRI support.

The university recommends 52-week postgraduate budgeting. Its essentials table, with an accommodation component labelled 2025/26, gives private-house essentials of £12,532–13,156/year and self-catered halls of £13,936–14,560. Subtracting these from the historical £21,805 reference leaves £8,649–9,273 or £7,245–7,869 respectively, before transport, leisure, eating out, clothing, arrival costs and price changes. This is arithmetic budget headroom, not predicted savings. Saved room-search examples of £147/week shared-bathroom housing versus £230–233/week ensuite rooms show why room type and contract length matter. No 2027 room or rate is guaranteed. Budget, room examples.

Apply through the exact project-linked 975E programme, naming the project and supervisor. Birmingham's MIBTP instructions require CV, English transcripts/certificates, research-methods training answer, references and the separate EDI form; at least one referee should be academic. A proposal is not required, and the mandatory proposal upload can take a blank document; the personal statement is optional, with N/A allowed in its mandatory box. One project per programme and up to five separate programme applications are permitted. The subject's IELTS 6.5/no band below 6.0 is a reference to confirm on the MIBTP offer; language evidence can follow initial submission. The saved guidance anticipates early-February 2027 overseas Zoom interviews, but exact deadline clock time and reference cut-off remain unresolved.

Applicant Fit, Preparation and Career Implications

Formal conditions are academic/English eligibility and the competition's submission rules. No mandatory journal paper, previous Kaede experience or machine-learning mastery is advertised. Useful backgrounds include immunology, cardiovascular/respiratory or vascular biology and quantitative bioscience, with willingness to undertake animal/imaging work and cross-campus training. A strictly coding-only expectation or inability to work a shared lab rota would conflict with the advertised research mode.

Suggested preparation is evidence of a prior research contribution, clear quantitative reasoning, reproducible image/omics analysis and the ability to distinguish observation from causal inference. The application need not contain an unsolicited detailed animal protocol. Demonstrating learning capacity on the weaker side of the experiment/computation interface is more credible than claiming all listed methods as prior expertise.

Career and transferable skills

The transferable value includes immunology/vascular research, quantitative microscopy, omics interpretation and bioscience data work. The BMVBS 2026 programme shows an active vascular-inflammation/imaging community and early-career development. UK 2026 life-sciences indicators describe broad industry investment, not a count of jobs in immune organotropism. Academic, biotechnology and research-data pathways are plausible skills-based inferences; the doctorate alone confers no clinical professional registration. Professional field activity, sector evidence.

Next Actions and Questions to Verify

Before applying: confirm the live 975E link, degree equivalence, project availability, deadline time and reference completion rule. Prepare the MIBTP-specific documents by 23 November 2026. Supervisor email can clarify fit but does not submit an application.

At interview: ask for the minimum feasible organ/context comparison, how origin tracking and the causal test form a doctorate-sized core, allocation between Juma and Laura, animal/imaging training and rota, protected equipment time, patient-data permissions and the placement schedule.

Before accepting: obtain four-year support and full international tuition in the offer, the 2027/28 stipend/payment schedule, research/placement travel and accommodation coverage, and a realistic 52-week personal budget including visa/IHS and arrival expenses.

Evidence and sources

The project and programme information cited here does not confirm whether the opportunity remains open or whether an individual will receive an award. Individual research permissions, resource allocations, and 2027 funding or cost arrangements remain to be confirmed.

Project, registration and funding

• S01 — Official immune-organotropism MIBTP project and supervision
• S02 — Birmingham MIBTP 2027 projects, funding and application instructions
• S03 — MIBTP application and eligibility for October 2027
• S04 — MIBTP frequently asked questions
• S05 — MIBTP 2025 Training Programme
• S16 — Cardiovascular Sciences research degree and training environment
• S17 — Birmingham postgraduate research entry requirements
• S18 — Birmingham guidance for applicants with Chinese qualifications

Supervisors, papers and facilities

• S06 — Juma El-Awaisi official staff profile
• S07 — Laura Bravo Merodio official staff profile
• S08 — Impact of chronic hyperglycaemia on the coronary microcirculation
• S09 — Organ-specific Syk inhibition and thromboinflammation in sickle-cell mice
• S10 — A Network-Based Association of IBD and Colorectal Cancer Using Proteomics Data
• S12 — University of Birmingham league tables
• S13 — Birmingham REF 2021 results
• S14 — Birmingham microcirculation research and intravital imaging facility

Costs, field and careers

• S19 — UKRI support for funded students
• S20 — Birmingham managing your money: postgraduate living-cost guidance
• S21 — Birmingham student room search
• S22 — BMVBS 2026 microvascular research programme
• S23 — UK Life Sciences Competitiveness Indicators 2026 summary